11 Results for "

hA2A

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "hA2A" in MCE Product Catalog:

Cat. No.: HY-14365
CAS No.: 1061747-72-5
Purity:  98.11%
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

TC-G 1004 (compound 16j) is an orally active A2A adenosine receptor antagonist, with Ki values of 0.44 nM and 80 nM for hA2A and hA1, respectively .
loading...
    loading...
Cat. No.: HY-146979
CAS No.: 2548963-55-7
Research Areas:  

Cancer

hA2A/hCA XII modulator 1 (compound 14), a triazolopirazine, is a potent hA2A adenosine receptor (hA2AAR) antagonist with Kis of 6.4 nM, 4.819 μM, >30 μM for hA2AAR, hA1AR, hA3AR, respectively. hA2A/hCA XII modulator 1 is a potent human carbonic anhydrase XII (hCA XII) inhibitor with Kis of 6.2 nM, 46 nM, 466 nM, 8.351 μM for hCA XII, hCA II, hCA IX and hCA I, respectively. hA2A/hCA XII modulator 1 has the potential for cancer research .
loading...
    loading...
Cat. No.: HY-103177
CAS No.: 591771-91-4
Target:  

Adenosine Receptor

Research Areas:  

Inflammation/Immunology

PSB-10 hydrochloride is a potent and selective antagonist of human adenosine A3 receptor (A3AR), with a Ki of 0.44 nM. PSB-10 hydrochloride shows more than 800-fold selectivity for hA3 over rA1, rA2A, hA1, hA2A and hA2B receptors (Ki=805, 6040, 1700, 2700, 30000 nM, respectively). PSB-10 hydrochloride produces thermal hyperalgesia in mice [2].
loading...
    loading...
Cat. No.: HY-149647
CAS No.: 606148-05-4
Target:  

JAK STAT

Research Areas:  

Inflammation/Immunology

HA-2a can inhibit the JAK2/STAT3 pathway via downregulates circDcbld2 expression in RAW264.7 cells .
loading...
    loading...
Cat. No.: HY-144115
CAS No.: 2760128-99-0
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

A1AR antagonist 1 (compound 18g) is a potent A1 adenosine receptor (AR) antagonist with Kis of 2.08, 6.91, and 31.2 nM for hA1, hA2A and hA2B, respectively .
loading...
    loading...
Cat. No.: HY-144116
CAS No.: 1441961-74-5
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

A1AR antagonist 2 (compound 18h) is a potent A1 adenosine receptor (AR) antagonist with Kis of 1.49, 10.2, and 50.1 nM for hA1, hA2A and hA2B, respectively .
loading...
    loading...
Cat. No.: HY-147541
CAS No.: 1448221-36-0
Target:  

Adenosine Receptor

Research Areas:  

Inflammation/Immunology

A2A/A3 AR antagonist-1 (compound 23) is a dual A2A/A3 adenosine receptor (AR) fluorescent ligand, with Kis of 90 nM and 31.8 nM for hA2A AR and hA3 AR, respectively .
loading...
    loading...
Cat. No.: HY-110186
CAS No.: 910045-32-8
Target:  

Adenosine Receptor

Research Areas:  

Metabolic Disease

PQ-69 is a potent and selective adenosine A1 receptor antagonist with inverse agonist activity. PQ-69 binds to hA1 receptor with a Ki value of 0.96 nM, is 217-fold more selective compared with hA2A receptors (Ki=208 nM) and >1,000-fold selectivity over hA3 receptor (Ki >100 μM). PQ-69 can be used for the research of renal dysfunction .
loading...
    loading...
Cat. No.: HY-115862
CAS No.: 53439-81-9
Benzo[c][1,8]naphthyridin-6(5H)-one exhibits low micromolar affinity to human adenosine receptor (AR) A1 and hA2A, with Ki of 4.6 and 4.8 μM. Benzo[c][1,8]naphthyridin-6(5H)-one is inhibitor for poly ADP-ribose polymerase-1 (PARP-1) and aurora kinase A, with IC50 of 0.311 and 5.5 μM [2] .
loading...
    loading...
Cat. No.: HY-170525
CAS No.: 333329-22-9
Target:  

CD73

Research Areas:  

Inflammation/Immunology

CD73-IN-19 (Compound 4ab) is a CD73 inhibitor (with a 44% inhibition rate of CD73 enzymatic activity at 100 μM). CD73-IN-19 (at 10 μM and 100 μM) can completely antagonize the blockade of T cell proliferation induced by TCR (T cell receptor) triggering (which is induced by CD73 activity), and it can also inhibit the hA2A receptor activity in HEK-293 cells (Ki is 3.31 μM). CD73-IN-19 holds promise for research in the field of immune diseases .
loading...
    loading...
Cat. No.: HY-180424
CAS No.: 352692-70-7
SYAF080 is a human A₂B adenosine receptor (hA₂B AdoR) antagonist with a Ki of 23.6 nM and a KB of 25.2 nM. SYAF080no relevant inhibition of human CYP450 cytochromes. SYAF080 can be used for the research of inflammation, metabolic and cardiovascular disease .
loading...
    loading...
  • 1